When treating Epilepsy, Alzheimer’s, Parkinson’s Disease, Obsessive Compulsive Disorder, anxiety and mood disorders, OCD or PTSD, the existing psychiatric and neurological protocols are not very effective and leave a large proportion of the population with undertreated symptoms and side effects.
For example, 40-60% of patients do not fully respond to medications, and there are side effects in over 60% of cases.
In addition, dependence, withdrawal, and longterm use issues can be experienced. In terms of psychotherapy, the expenses and time combined with the variable quality of treatment and practitioners, results in 40-50% of patients who do not want, or do not respond to psychological treatment.
BrainSonix has developed medical technology platform based on proprietary Low Intensity Focused Ultrasound Pulsation (LIFUP) to modulate the brain function non-invasively without any harmful or irreversible effects on the brain and body. Our patented technology allows targeting of specific neuronal circuits using fMRI, identification of malfunctioning circuits using fMRI “feedback” and repair of the circuits using LIFUP to activate or inhibit them.